Merrion Management Team To Split Time Between U.S., Ireland
This article was originally published in The Pink Sheet Daily
The new executives at the oral drug delivery company include former Abbott exec John Lynch, who will be located at Merrion's R&D headquarters in Ireland. Chief Scientific Officer Thomas Leonard, PhD, will be based at the U.S. corporate office.
You may also be interested in...
Despite giving up on inhaled insulin earlier this year, deal continues Novo Nordisk’s focus on enhancements to insulin formulation and delivery.
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.